Adaptimmune Therapeutics shares owned by Hunter Associates
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Hunter Associates
from 13F filings
Historical chart of Hunter Associates investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Hunter Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Hunter Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $19k | 23k | 0.83 |
| 2023-09-30 | $20k | 24k | 0.83 |
| 2023-06-30 | $24k | 26k | 0.94 |
| 2023-03-31 | $28k | 26k | 1.10 |
| 2022-12-31 | $38k | 27k | 1.41 |
| 2022-09-30 | $31k | 29k | 1.09 |
| 2022-06-30 | $49k | 29k | 1.72 |
| 2022-03-31 | $41k | 20k | 2.05 |
| 2021-12-31 | $41k | 11k | 3.73 |
| 2021-06-30 | $84k | 16k | 5.31 |
| 2021-03-31 | $84k | 16k | 5.31 |